RecruitingNCT06084013

Use Of Indocyanine Green In Pancreas Surgery

Assessing the Role of Intraoperative Indocyanine Green Perfusion of the Transected Pancreas in Predicting Postoperative Pancreatic Leaks


Sponsor

OHSU Knight Cancer Institute

Enrollment

55 participants

Start Date

May 17, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether using a fluorescent dye called indocyanine green (ICG), which makes blood flow visible under special imaging, can improve outcomes in pancreas surgery. Surgeons use ICG to assess tissue blood supply during the operation to reduce complications. **You may be eligible if...** - You are 18 or older and scheduled for open pancreas surgery (pancreaticoduodenectomy or distal pancreatectomy) for any reason - You understand the trial and have given written consent - You will have a surgical drain placed after the procedure - If you could become pregnant, you have a negative pregnancy test and will use contraception for 14 days after the procedure **You may NOT be eligible if...** - You have a known allergy to ICG dye or contrast agents - You have previously had pancreas surgery - You have liver disease (hepatitis, cirrhosis, liver failure) or chronic pancreatitis - You experienced serious complications after surgery (e.g., dangerously low blood pressure, blood transfusion, unexpected ICU transfer) - Your surgery requires complex artery reconstruction Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(1)

OHSU Knight Cancer Institute

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06084013


Related Trials